Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
International Journal of Cancer
|
September 24, 2004
RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance
Rajendra Sharma, Sharad S Singhal, Dilki Wickramarachchi, et al.
The AAPS Journal
|
August 26, 2020
Fit-for-Purpose Validation and Establishment of Assay Acceptance and Reporting Criteria of Dendritic Cell Activation Assay Contributing to the Assessment of Immunogenicity Risk
Dilki Wickramarachchi, Gregory Steeno, Zhiping You, et al.
The AAPS Journal
|
January 25, 2023
A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies
Dilki Wickramarachchi, Julianne Wagner, Thomas Woo, et al.
Journal of Leukocyte Biology
|
July 21, 2010
Mast cell function is not altered by Coronin-1A deficiency
Sanja Arandjelovic, Dilki Wickramarachchi, Saskia Hemmers, et al.
FEBS Letters
|
April 4, 2006
Determinants of differential doxorubicin sensitivity between SCLC and NSCLC
Sharad S Singhal, Dilki Wickramarachchi, Jyotsana Singhal, et al.
Biochemistry
|
December 22, 2004
Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses
Sushma Yadav, Sharad S Singhal, Jyotsana Singhal, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis
Sharad S Singhal, Dilki Wickramarachchi, Sushma Yadav, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 18, 2010
Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice
Djemel Aït-Azzouzene, Dwight H Kono, Rosana Gonzalez-Quintial, et al.
Cancer Research
|
July 19, 2005
RLIP76 is a major determinant of radiation sensitivity
Sanjay Awasthi, Sharad S Singhal, Sushma Yadav, et al.
Clinical Drug Investigation
|
January 16, 2026
Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study
Andrew Ustianowski, Myron J Levin, Stephane De Wit, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
International Journal of Cancer
|
September 24, 2004
RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance
Rajendra Sharma, Sharad S Singhal, Dilki Wickramarachchi, et al.
The AAPS Journal
|
August 26, 2020
Fit-for-Purpose Validation and Establishment of Assay Acceptance and Reporting Criteria of Dendritic Cell Activation Assay Contributing to the Assessment of Immunogenicity Risk
Dilki Wickramarachchi, Gregory Steeno, Zhiping You, et al.
The AAPS Journal
|
January 25, 2023
A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies
Dilki Wickramarachchi, Julianne Wagner, Thomas Woo, et al.
Journal of Leukocyte Biology
|
July 21, 2010
Mast cell function is not altered by Coronin-1A deficiency
Sanja Arandjelovic, Dilki Wickramarachchi, Saskia Hemmers, et al.
FEBS Letters
|
April 4, 2006
Determinants of differential doxorubicin sensitivity between SCLC and NSCLC
Sharad S Singhal, Dilki Wickramarachchi, Jyotsana Singhal, et al.
Biochemistry
|
December 22, 2004
Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses
Sushma Yadav, Sharad S Singhal, Jyotsana Singhal, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis
Sharad S Singhal, Dilki Wickramarachchi, Sushma Yadav, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 18, 2010
Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice
Djemel Aït-Azzouzene, Dwight H Kono, Rosana Gonzalez-Quintial, et al.
Cancer Research
|
July 19, 2005
RLIP76 is a major determinant of radiation sensitivity
Sanjay Awasthi, Sharad S Singhal, Sushma Yadav, et al.
Clinical Drug Investigation
|
January 16, 2026
Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study
Andrew Ustianowski, Myron J Levin, Stephane De Wit, et al.
Page
of 1